U.S., Oct. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07217600) titled 'Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy' on April 30.
Brief Summary: The goal of this study is to evaluate the antiemetic efficacy and drug safety of ondansetron orodispersible film in pediatric patients with malignant tumors who received moderate emetic risk radiation induced vomiting, and to formulate reasonable and effective clinical medication regimen for preventing vomiting caused by moderate emetic risk radiation in children with malignant tumor.
Study Start Date: March 25
Study Type: INTERVENTIONAL
Condition:
Radiotherapy-induced Nausea and Vomiting (RINV)
Pediatric Cancer
Interv...